Annual Revenue
$29.55 B
-$278.56 M-0.93%
31 March 2024
Summary:
Takeda Pharmaceutical Company Limited annual revenue is currently $29.55 billion, with the most recent change of -$278.56 million (-0.93%) on 31 March 2024. During the last 3 years, it has fallen by -$618.36 million (-2.05%). TAK annual revenue is now -7.06% below its all-time high of $31.79 billion, reached on 31 March 2022.TAK Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$7.92 B
+$168.58 M+2.18%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited quarterly revenue is currently $7.92 billion, with the most recent change of +$168.58 million (+2.18%) on 01 September 2024. Over the past year, it has increased by +$696.28 million (+9.64%). TAK quarterly revenue is now -8.74% below its all-time high of $8.68 billion, reached on 30 June 2021.TAK Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$30.27 B
+$696.28 M+2.35%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited TTM revenue is currently $30.27 billion, with the most recent change of +$696.28 million (+2.35%) on 01 September 2024. Over the past year, it has increased by +$319.80 million (+1.07%). TAK TTM revenue is now -4.79% below its all-time high of $31.80 billion, reached on 31 March 2022.TAK TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.9% | +9.6% | +1.1% |
| 3 y3 years | -2.0% | +3.1% | -4.3% |
| 5 y5 years | +56.2% | +4.7% | +15.4% |
TAK Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.1% | at low | -0.1% | +11.8% | -4.8% | +2.5% |
| 5 y | 5 years | -7.1% | +56.2% | -8.7% | +11.8% | -4.8% | +15.4% |
| alltime | all time | -7.1% | +267.0% | -8.7% | +120.7% | -4.8% | +690.1% |
Takeda Pharmaceutical Company Limited Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.92 B(+2.2%) | $30.27 B(+2.4%) |
| June 2024 | - | $7.75 B(+9.4%) | $29.58 B(+0.1%) |
| Mar 2024 | $29.55 B(-0.9%) | $7.08 B(-5.9%) | $29.54 B(-0.5%) |
| Dec 2023 | - | $7.53 B(+4.2%) | $29.70 B(-0.8%) |
| Sept 2023 | - | $7.22 B(-6.4%) | $29.95 B(-0.1%) |
| June 2023 | - | $7.71 B(+6.6%) | $29.99 B(+0.7%) |
| Mar 2023 | $29.83 B(-6.2%) | $7.24 B(-6.9%) | $29.78 B(-0.9%) |
| Dec 2022 | - | $7.78 B(+7.2%) | $30.06 B(-0.5%) |
| Sept 2022 | - | $7.26 B(-3.3%) | $30.21 B(-1.4%) |
| June 2022 | - | $7.51 B(-0.2%) | $30.63 B(-3.7%) |
| Mar 2022 | $31.79 B(+5.4%) | $7.52 B(-5.2%) | $31.80 B(+0.8%) |
| Dec 2021 | - | $7.93 B(+3.3%) | $31.55 B(-0.3%) |
| Sept 2021 | - | $7.68 B(-11.5%) | $31.64 B(+0.8%) |
| June 2021 | - | $8.68 B(+19.3%) | $31.39 B(+4.1%) |
| Mar 2021 | $30.17 B(-0.4%) | $7.27 B(-9.2%) | $30.17 B(+0.6%) |
| Dec 2020 | - | $8.01 B(+7.8%) | $29.98 B(+0.4%) |
| Sept 2020 | - | $7.43 B(-0.2%) | $29.87 B(-0.4%) |
| June 2020 | - | $7.45 B(+5.2%) | $30.00 B(-0.9%) |
| Mar 2020 | $30.28 B(+60.1%) | $7.09 B(-10.3%) | $30.28 B(+1.9%) |
| Dec 2019 | - | $7.90 B(+4.5%) | $29.70 B(+13.2%) |
| Sept 2019 | - | $7.56 B(-2.1%) | $26.23 B(+16.4%) |
| June 2019 | - | $7.73 B(+18.6%) | $22.53 B(+19.0%) |
| Mar 2019 | $18.92 B(+18.4%) | $6.51 B(+47.0%) | $18.93 B(+17.5%) |
| Dec 2018 | - | $4.43 B(+14.6%) | $16.12 B(+0.7%) |
| Sept 2018 | - | $3.86 B(-6.3%) | $16.01 B(-0.3%) |
| June 2018 | - | $4.12 B(+11.5%) | $16.05 B(+0.6%) |
| Mar 2018 | $15.98 B(-0.2%) | $3.70 B(-14.4%) | $15.96 B(+0.2%) |
| Dec 2017 | - | $4.32 B(+10.7%) | $15.92 B(+0.4%) |
| Sept 2017 | - | $3.91 B(-3.2%) | $15.86 B(-1.0%) |
| June 2017 | - | $4.03 B(+10.2%) | $16.03 B(+0.1%) |
| Mar 2017 | $16.02 B(+6.3%) | $3.66 B(-14.1%) | $16.01 B(+0.4%) |
| Dec 2016 | - | $4.26 B(+4.6%) | $15.95 B(+1.5%) |
| Sept 2016 | - | $4.07 B(+1.3%) | $15.71 B(+2.1%) |
| June 2016 | - | $4.02 B(+11.8%) | $15.39 B(+2.3%) |
| Mar 2016 | $15.06 B | $3.59 B(-10.8%) | $15.05 B(-0.5%) |
| Dec 2015 | - | $4.03 B(+7.5%) | $15.13 B(-1.6%) |
| Sept 2015 | - | $3.75 B(+1.8%) | $15.37 B(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $3.68 B(+0.1%) | $15.86 B(-2.1%) |
| Mar 2015 | $16.26 B(-3.7%) | $3.67 B(-14.0%) | $16.21 B(-1.6%) |
| Dec 2014 | - | $4.27 B(+0.9%) | $16.47 B(-1.8%) |
| Sept 2014 | - | $4.24 B(+5.2%) | $16.76 B(+0.1%) |
| June 2014 | - | $4.02 B(+2.3%) | $16.75 B(-0.8%) |
| Mar 2014 | $16.89 B(-10.4%) | $3.94 B(-13.9%) | $16.88 B(-0.4%) |
| Dec 2013 | - | $4.57 B(+8.1%) | $16.94 B(-2.2%) |
| Sept 2013 | - | $4.23 B(+1.7%) | $17.33 B(-4.0%) |
| June 2013 | - | $4.15 B(+4.0%) | $18.05 B(-4.3%) |
| Mar 2013 | $18.84 B(-1.5%) | $3.99 B(-19.3%) | $18.86 B(-4.2%) |
| Dec 2012 | - | $4.95 B(+0.2%) | $19.68 B(-2.7%) |
| Sept 2012 | - | $4.94 B(-0.5%) | $20.22 B(+2.5%) |
| June 2012 | - | $4.97 B(+3.2%) | $19.72 B(+3.1%) |
| Mar 2012 | $19.12 B(+16.0%) | $4.81 B(-12.4%) | $19.13 B(+3.8%) |
| Dec 2011 | - | $5.49 B(+23.7%) | $18.43 B(+6.0%) |
| Sept 2011 | - | $4.44 B(+1.4%) | $17.38 B(+1.5%) |
| June 2011 | - | $4.38 B(+6.5%) | $17.12 B(+3.2%) |
| Mar 2011 | $16.48 B(+4.3%) | $4.11 B(-7.5%) | $16.59 B(+2.4%) |
| Dec 2010 | - | $4.44 B(+6.3%) | $16.20 B(+1.9%) |
| Sept 2010 | - | $4.18 B(+8.5%) | $15.91 B(+1.0%) |
| June 2010 | - | $3.85 B(+3.5%) | $15.75 B(-0.2%) |
| Mar 2010 | $15.80 B(+2.1%) | $3.72 B(-10.2%) | $15.79 B(+0.9%) |
| Dec 2009 | - | $4.15 B(+2.9%) | $15.65 B(+0.1%) |
| Sept 2009 | - | $4.03 B(+3.5%) | $15.64 B(+1.3%) |
| June 2009 | - | $3.89 B(+8.4%) | $15.45 B(+33.7%) |
| Mar 2009 | $15.47 B(+28.2%) | $3.59 B(-13.2%) | $11.56 B(+45.0%) |
| Dec 2008 | - | $4.14 B(+7.9%) | $7.97 B(+107.9%) |
| Sept 2008 | - | $3.83 B | $3.83 B |
| Mar 2008 | $12.06 B(+8.1%) | - | - |
| Mar 2007 | $11.16 B(+4.1%) | - | - |
| Mar 2006 | $10.72 B(+2.5%) | - | - |
| Mar 2005 | $10.46 B(+8.6%) | - | - |
| Mar 2004 | $9.64 B(+12.2%) | - | - |
| Mar 2003 | $8.59 B(+6.7%) | - | - |
| Mar 2002 | $8.05 B(-7.8%) | - | - |
| Mar 2001 | $8.73 B(+4.9%) | - | - |
| Mar 2000 | $8.32 B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual revenue?
- What is the all time high annual revenue for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual revenue year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly revenue?
- What is the all time high quarterly revenue for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly revenue year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM revenue?
- What is the all time high TTM revenue for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM revenue year-on-year change?
What is Takeda Pharmaceutical Company Limited annual revenue?
The current annual revenue of TAK is $29.55 B
What is the all time high annual revenue for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual revenue is $31.79 B
What is Takeda Pharmaceutical Company Limited annual revenue year-on-year change?
Over the past year, TAK annual revenue has changed by -$278.56 M (-0.93%)
What is Takeda Pharmaceutical Company Limited quarterly revenue?
The current quarterly revenue of TAK is $7.92 B
What is the all time high quarterly revenue for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly revenue is $8.68 B
What is Takeda Pharmaceutical Company Limited quarterly revenue year-on-year change?
Over the past year, TAK quarterly revenue has changed by +$696.28 M (+9.64%)
What is Takeda Pharmaceutical Company Limited TTM revenue?
The current TTM revenue of TAK is $30.27 B
What is the all time high TTM revenue for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM revenue is $31.80 B
What is Takeda Pharmaceutical Company Limited TTM revenue year-on-year change?
Over the past year, TAK TTM revenue has changed by +$319.80 M (+1.07%)